OBJECTIVE: To evaluate the safety and utility of core needle biopsy (CNB) for diagnosis of salivary gland lymphoma in Sjögren's syndrome (SS). METHODS: We analyzed data from consecutive SS patients who underwent ultrasound-guided major salivary gland CNB for lymphoma diagnosis and determined whether CNB yielded an actionable diagnosis without need for further intervention. RESULTS: CNBs were performed in 24 patients to evaluate discrete parotid (n = 6) or submandibular (n = 2) gland masses or diffuse enlargement (n = 16; 15 parotid). One patient had 3 CNBs of the same mass. Of the 26 CNBs, 24 included flow cytometry, using CNB and/or fine needle aspirate material, and 14 targeted sonographically identified focal lesions. No patient reported complications. In the 23 patients with 1 CNB, final diagnoses were marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT; n = 6), atypical lymphoid infiltration (n = 3), benign lymphoepithelial sialadenitis (n = 9), normal gland tissue (n = 4), and lymphoepithelial cyst (n = 1). In the patient with serial CNBs, the initial one without flow cytometry was benign, but the next 2 showed atypical lymphoid infiltration. Monoclonal lymphoid infiltration was detected in 12 patients: 6 with MALT lymphoma, 3 were benign, and 3 with atypical lymphoid infiltration. Of the latter 3, 1 was treated with rituximab and 2 with expectant observation. The diagnosis changed from atypical lymphoid infiltration to MALT lymphoma in 1 patient following biopsy of inguinal adenopathy 6 months post-CNB. CNB provided actionable results and avoided open excisional biopsies in all cases. CONCLUSION: CNB is safe and useful in the evaluation of suspected salivary gland lymphoma in SS.
OBJECTIVE: To evaluate the safety and utility of core needle biopsy (CNB) for diagnosis of salivary gland lymphoma in Sjögren's syndrome (SS). METHODS: We analyzed data from consecutive SS patients who underwent ultrasound-guided major salivary gland CNB for lymphoma diagnosis and determined whether CNB yielded an actionable diagnosis without need for further intervention. RESULTS: CNBs were performed in 24 patients to evaluate discrete parotid (n = 6) or submandibular (n = 2) gland masses or diffuse enlargement (n = 16; 15 parotid). One patient had 3 CNBs of the same mass. Of the 26 CNBs, 24 included flow cytometry, using CNB and/or fine needle aspirate material, and 14 targeted sonographically identified focal lesions. No patient reported complications. In the 23 patients with 1 CNB, final diagnoses were marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT; n = 6), atypical lymphoid infiltration (n = 3), benign lymphoepithelial sialadenitis (n = 9), normal gland tissue (n = 4), and lymphoepithelial cyst (n = 1). In the patient with serial CNBs, the initial one without flow cytometry was benign, but the next 2 showed atypical lymphoid infiltration. Monoclonal lymphoid infiltration was detected in 12 patients: 6 with MALT lymphoma, 3 were benign, and 3 with atypical lymphoid infiltration. Of the latter 3, 1 was treated with rituximab and 2 with expectant observation. The diagnosis changed from atypical lymphoid infiltration to MALT lymphoma in 1 patient following biopsy of inguinal adenopathy 6 months post-CNB. CNB provided actionable results and avoided open excisional biopsies in all cases. CONCLUSION: CNB is safe and useful in the evaluation of suspected salivary gland lymphoma in SS.
Authors: Sandrine Jousse-Joulin; Maria Antonietta D'Agostino; Alojzija Hočevar; Esperanza Naredo; Lene Terslev; Sarah Ohrndorf; Annamaria Iagnocco; Wolfgang A Schmidt; Stephanie Finzel; Zarrin Alavi; George A W Bruyn Journal: Ann Rheum Dis Date: 2019-10-10 Impact factor: 19.103
Authors: Michael Voulgarelis; Panayiotis D Ziakas; Aristea Papageorgiou; Evangelia Baimpa; Athanasios G Tzioufas; Haralampos M Moutsopoulos Journal: Medicine (Baltimore) Date: 2012-01 Impact factor: 1.889
Authors: Rodney P E Pollard; Justin Pijpe; Hendrika Bootsma; Fred K L Spijkervet; Philip M Kluin; Jan L N Roodenburg; Cees G M Kallenberg; Arjan Vissink; Gustaaf W van Imhoff Journal: J Rheumatol Date: 2011-08-15 Impact factor: 4.666
Authors: A Stacchini; S Aliberti; D Pacchioni; A Demurtas; G Isolato; C Gazzera; A Veltri; F Maletta; L Molinaro; D Novero Journal: Cytopathology Date: 2013-07-19 Impact factor: 2.073
Authors: Monica R Drylewicz; Marcus P Watkins; Anup S Shetty; Michael F Lin; Amber Salter; Nancy L Bartlett; William D Middleton; Motoyo Yano Journal: J Ultrasound Med Date: 2018-07-25 Impact factor: 2.153
Authors: Caroline H Shiboski; Stephen C Shiboski; Raphaèle Seror; Lindsey A Criswell; Marc Labetoulle; Thomas M Lietman; Astrid Rasmussen; Hal Scofield; Claudio Vitali; Simon J Bowman; Xavier Mariette Journal: Ann Rheum Dis Date: 2016-10-26 Impact factor: 19.103
Authors: Sara Zandonella Callegher; Alen Zabotti; Ivan Giovannini; Elena Treppo; Luca Quartuccio; Salvatore De Vita Journal: Front Med (Lausanne) Date: 2020-12-09
Authors: Esther Mossel; Martha S van Ginkel; Erlin A Haacke; Suzanne Arends; Silvia C Liefers; Konstantina Delli; Jolien F van Nimwegen; Alja J Stel; Fred K L Spijkervet; Arjan Vissink; Bert van der Vegt; Frans G M Kroese; Hendrika Bootsma Journal: Rheumatology (Oxford) Date: 2022-05-30 Impact factor: 7.046
Authors: Michele Lorenzon; Erica Spina; Francesco Tulipano Di Franco; Ivan Giovannini; Salvatore De Vita; Alen Zabotti Journal: Open Access Rheumatol Date: 2022-09-01